Literature DB >> 2921037

Incontinentia pigmenti and X-autosome translocations. Non-isotopic in situ hybridization with an X-centromere-specific probe (pSV2X5) reveals a possible X-centromeric breakpoint in one of five published cases.

J A Crolla1, S Gilgenkrantz, J de Grouchy, T Kajii, M Bobrow.   

Abstract

Incontinentia pigmenti (IP) is a rare X-linked disease with marked female-to-female transmission and a dominant pattern of inheritance. Reports of six unrelated females with IP and X-autosomal translocations, all with the X breakpoint at Xp11, and an additional report of a female with IP and a 45,X/46,X,r(X) karyotype suggests that this may be the locus for the IP gene. When four of these cases, including the r(X), were re-examined with a non-isotopic in situ hybridization technique and an X centromere-specific probe (pSV2X5), the Xp11 breakpoint was confirmed. However, results from a fifth reported case, t(X;17), showed that the X breakpoint was within the centromeric alphoid repetitive sequences recognized by the probe pSV2X5. As the clinical presentation of this patient was consistent with the IP phenotype and diagnosis, the centromeric position of the X-chromosome breakpoint raises several questions with respect to the homogeneity of the Xp11 locus for IP.

Entities:  

Mesh:

Year:  1989        PMID: 2921037     DOI: 10.1007/BF00279002

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  20 in total

1.  X;15 translocation in a retarded girl: X inactivation pattern and attempt to localise the hexosaminidase A and other loci.

Authors:  R Bernstein; B Dawson; R Kohl; T Jenkins
Journal:  J Med Genet       Date:  1979-08       Impact factor: 6.318

2.  Tentative assignment of hypomelanosis of Ito to 9q33----qter.

Authors:  R Happle
Journal:  Hum Genet       Date:  1987-01       Impact factor: 4.132

3.  Organization and evolution of alpha satellite DNA from human chromosome 11.

Authors:  J S Waye; L A Creeper; H F Willard
Journal:  Chromosoma       Date:  1987       Impact factor: 4.316

4.  Characterization of human centromeric regions of specific chromosomes by means of alphoid DNA sequences.

Authors:  E W Jabs; M G Persico
Journal:  Am J Hum Genet       Date:  1987-09       Impact factor: 11.025

5.  Translocation (X;9)(p11;q34) in a girl with incontinentia pigmenti (IP): implications for the regional assignment of the IP locus to Xp11?

Authors:  S Gilgenkrantz; P Tridon; N Pinel-Briquel; J Beurey; M Weber
Journal:  Ann Genet       Date:  1985

6.  Meiosis in the foetal mouse ovary. II. Oocyte development and age-related aneuploidy. Does a production line exist?

Authors:  R M Speed; A C Chandley
Journal:  Chromosoma       Date:  1983       Impact factor: 4.316

7.  Genetic mapping: X chromosome.

Authors:  B Keats
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

8.  Two cases of X/autosome translocation in females with incontinentia pigmenti.

Authors:  S V Hodgson; B Neville; R W Jones; C Fear; M Bobrow
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

9.  Gene for incontinentia pigmenti maps to band Xp11 with an (X;10) (p11;q22) translocation.

Authors:  L A Cannizzaro; F Hecht
Journal:  Clin Genet       Date:  1987-07       Impact factor: 4.438

10.  X-autosome translocations: cytogenetic characteristics and their consequences.

Authors:  M G Mattei; J F Mattei; S Ayme; F Giraud
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

View more
  10 in total

1.  Exclusion mapping of the X-linked dominant chondrodysplasia punctata/ichthyosis/cataract/short stature (Happle) syndrome: possible involvement of an unstable pre-mutation.

Authors:  H Traupe; D Müller; D Atherton; D C Kalter; F P Cremers; B A van Oost; H H Ropers
Journal:  Hum Genet       Date:  1992-08       Impact factor: 4.132

2.  Familial whole-arm translocations (1;19), (9;13), and (12;21): a review of 101 constitutional exchanges.

Authors:  Alejandra Vázquez-Cárdenas; Ana I Vásquez-Velásquez; Patricio Barros-Núñez; Johana Mantilla-Capacho; Mariano Rocchi; Horacio Rivera
Journal:  J Appl Genet       Date:  2007       Impact factor: 3.240

Review 3.  X linked mental retardation.

Authors:  I A Glass
Journal:  J Med Genet       Date:  1991-06       Impact factor: 6.318

4.  X inactivation analysis in a female with hypomelanosis of Ito associated with a balanced X;17 translocation: evidence for functional disomy of Xp.

Authors:  E Hatchwell; D Robinson; J A Crolla; A E Cockwell
Journal:  J Med Genet       Date:  1996-03       Impact factor: 6.318

5.  A mosaic 45,X/46,X,r(?) karyotype investigated with X and Y centromere-specific probes using a non-autoradiographic in situ hybridization technique.

Authors:  J A Crolla; J C Llerena
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

Review 6.  Mendelian cytogenetics. Chromosome rearrangements associated with mendelian disorders.

Authors:  N Tommerup
Journal:  J Med Genet       Date:  1993-09       Impact factor: 6.318

7.  Fluorescence in situ hybridization reveals a break in the alpha-satellite DNA of chromosome 1 in a family with a balanced whole-arm translocation.

Authors:  C H Gravholt; M Caprani; U Friedrich
Journal:  Hum Genet       Date:  1994-11       Impact factor: 4.132

8.  Dominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone disease.

Authors:  Anjli Kukreja; Soroosh Radfar; Ben-Hua Sun; Karl Insogna; Madhav V Dhodapkar
Journal:  Blood       Date:  2009-08-06       Impact factor: 22.113

9.  Localization of DNA sequences to a region within Xp11.21 between incontinentia pigmenti (IP1) X-chromosomal translocation breakpoints.

Authors:  J L Gorski; E N Burright; C E Harnden; C K Stein; T W Glover; E L Reyner
Journal:  Am J Hum Genet       Date:  1991-01       Impact factor: 11.025

10.  A non-isotopic in situ hybridisation study of the chromosomal origin of 15 supernumerary marker chromosomes in man.

Authors:  J A Crolla; N R Dennis; P A Jacobs
Journal:  J Med Genet       Date:  1992-10       Impact factor: 6.318

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.